Cost and cost-effectiveness analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis

Nkgomeleng Lekodeba, Katherine Snyman, Brooke E Nichols, Lise Jamieson
doi: https://doi.org/10.1101/2024.12.13.24319006
Back to top
Posted December 14, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Cost and cost-effectiveness analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis
Nkgomeleng Lekodeba, Katherine Snyman, Brooke E Nichols, Lise Jamieson
medRxiv 2024.12.13.24319006; doi: https://doi.org/10.1101/2024.12.13.24319006
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area